Since 2022, Detechgene operates as a Cologne-based biotech company headquartered at BioCampus Cologne. With 400m2 of ISO 9001 and ISO 13485 certified laboratory space, we integrate lab development and engineering at one site to accelerate development and translate innovation into scalable diagnostic solutions.
We deliver a rapid molecular testing platform that combines nucleic-acid detection with rapid-test usability. Built on isothermal amplification, it supports customizable pathogen panels across viral, bacterial, fungal and additional targets for the detection of infectious disease at the point of need.
Learn more
Headquartered at BioCampus Cologne, Detechgene benefits from a strong life-science ecosystem that supports robust R&D and enables close collaboration with University Hospital Cologne and leading clinical partners across North Rhine–Westphalia.
This environment helps translate research into diagnostic relevant solutions and supports regional, independent capabilities across key development activities
Born out of academic research, Detechgene was founded with a single ambition – to make diagnostics accessible for everyone and everywhere.
The concept for Detechgene emerged during the COVID-19 pandemic within the nephrology research laboratory at University Hospital Cologne. The team experienced first-hand how quickly existing diagnostic pathways reached their limits.
The underlying approach was evaluated and validated as a proof of concept at CECAD in Cologne. The first concept envisioned mobile nucleic-acid amplification in a cartridge-based format.
Building on these results, Detechgene was founded to develop portable, precise, and easy-to-use molecular diagnostics that can bring PCR-level performance closer to where clinical decisions are made. The company establishes headquarters at BioCampus Cologne with 400 m² of laboratory space.
Supported by ZukunftBIO.NRW, €4.4M in funding across two financing rounds (€1.2M pre-seed and €3.2M seed) and recently recognized with the WiNa Award – Detechgene has showcased its technology internationally, including at Web Summit Qatar as part of the German Delegation NRW.
Total Funding Raised
Pre-seed + Seed
International Collaboration
Qatar · Japan · Nigeria · China · Italy
Awards & Finals
Pitch competitions
Our development has been accelerated by strong institutional support and reinforced collaborations with leading clinical and academic partners in NRW.
Co-Founder & CEO
PhD in Biology (University of Cologne) and MBA in Business Development. With 10+ years of excellence research in genetics and ageing, including international research experience at Monash University and Harvard Medical School, he leads Detechgene's laboratory development and business strategy.
Co-Founder & CTO
Studied biomedical engineering and earned a PhD in molecular medicine. With 14+ years in life-science R&D, patented methods, and peer-reviewed publications, he previously led development at the Scientific Workshop of University Hospital Cologne and now drives Detechgene's technology roadmap, engineering, and implementation
Founding category
University of Cologne
Business Insider / Springer
Detechgene is built by a team of 18 – R&D scientists, engineers and specialists across quality management, sales and marketing. Together, we bring the full expertise needed to develop, validate and bring diagnostic solutions to market. We are grateful to every team member driving this mission forward.
Whether you're a researcher, engineer, or partner — we'd love to connect and explore what we can build together.
